The BIOFIRE System is the new standard for syndromic infectious disease diagnostics. Simple, fast, and comprehensive, the BIOFIRE System delivers accurate results in about one hour.

BioFire ® FilmArray ® Panels Comprehensive Panels and Better Diagnostics Comprehensive panels take out the guess work, giving laboratories and healthcare providers a higher probability of …

The BioFire FilmArray helps healthcare providers improve patient care and satisfaction by providing comprehensive syndromic testing, faster results and better results.

BioFire is now bioMérieux: One Company. One Future. Endless Possibilities. Bad bugs are constantly evolving—and so is the BioFire brand. BioFire was acquired in 2014 by bioMérieux SA, a global …

BioFire Support Assisting You with World Class Support Excellence in customer support is a value deeply ingrained in the culture of BioFire. We want to provide our customers with the information …

Point-of-Care PCR Testing Systems BIOFIRE® SPOTFIRE® System The SPOTFIRE System is the latest advancement in PCR infectious disease diagnostics. Designed for use with our CLIA waived …

BioFire’s syndromic approach combines a broad grouping of probable pathogens into a single, rapid test. With the BioFire RP2.1plus Panel, all it takes is one test and just 45 minutes to identify 23 …

Syndromic PCR testing from BioFire positively impacts patients, physicians, and everyone in between. Each panel offers several proven benefits and empowers healthcare providers to choose the right …

Background The BioFire Respiratory Panel 2.1 (RP2.1) is a PCR-based multiplexed nucleic acid test intended for use with the BioFire® 2.0 or BioFire® Torch Systems for the simultaneous qualitative …

The FDA De Novo authorized BioFire RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19.